TMO stock: buy or sell?
Updated on:
October 18th, 2019
3
Thermo Fisher Scientific Inc. provides analytical instruments, equipment, reagents and consumables, software, and services for research, manufacturing, analysis, discovery, and diagnostics under Thermo Scientific, Applied Biosystems, Invitrogen, Fisher Scientific, and Unity Lab Services brands worldwide.
Should I buy TMO stock?
Trading stocks requires experience and discipline, and your buying and selling decisions must come following a methodology. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. There are thousands of trading strategies for you to choose, but at Stocks2.com we prefer those that are simple but successful.Currently, Thermo Fisher Scientific stock doesn't match any of these trading strategies, so our recommendation is not to buy.
| Buy setup | Elegible |
|---|---|
| New all-time high | No |
| New 52 week high | No |
| Price crossing up 200d MA | No |
| 100d MA crossing up 200d MA | No |
Is Thermo Fisher Scientific stock a buy?
Everyday, hundreds of stock ratings are posted by financial analysts to indicate a particular stock's attractiveness.
At Stocks2.com, we gathered 12 ratings published for TMO stock in the last 30 days. The general sentiment of these ratings is bullish for TMO stock, with 12 positive ratings.| Date | Analyst / Broker | Previous rating | Current rating |
| 2019-9-26 | Liberum Capital | n/a | Buy |
| 2019-7-25 | Needham & Company LLC | n/a | Buy |
| 2019-7-16 | Needham & Company LLC | Strong-Buy | Buy |
| 2019-5-23 | UBS Group | n/a | Buy |
| 2019-4-16 | Bank of America | Buy | Buy |
| 2019-3-26 | Robert W. Baird | Outperform | Outperform |
| 2019-3-26 | BTIG Research | n/a | Buy |
| 2019-3-25 | UBS Group | n/a | Buy |
| 2019-3-22 | Deutsche Bank | n/a | Buy |
| 2019-3-18 | Barclays | Overweight | Overweight |
| 2019-1-31 | BTIG Research | n/a | Buy |
| 2019-1-3 | Barclays | Overweight | Overweight |
TMO stock analysis
Daily outlook
Thermo Fisher Scientific closed on October/18 at $281.42 and remained stable a neutral -0.06%.
Thermo Fisher Scientific shares remained stable -0.06% to $281.42 on Oct/18. TMO is soaring again after a 3.00% correction from its last top on Tuesday at $287.97. On July, TMO hit a new all time high, pushing higher than on July tops. Check different trading setups that use ATHs as triggers.
Weekly outlook
Shares of Thermo Fisher Scientific declined a bad -0.78% this week. Late August TMO skyrocketed a dazzling 6.17% in just one week.
Far behind is the all-time high Thermo Fisher Scientific hit early July but price is just -7.81% below that top. Early January TMO price bounced up over the SMA of 40 weeks that acted as support stopping new slides.
TMO stock price history
TMO IPO was on March 17th, 1980 at $0.00 per share1. Since then, TMO stock surged a inf%, with an average of inf% per year. If you had invested $1,000 in TMO stock in 1980, it would worth $inf today.
1: Adjusted price after possible price splits or reverse-splits.
TMO stock historical price chart
TMO stock reached all-time highs on July with a price of $305.26.
TMO stock price target is $302.60
How much a stock will be priced tomorrow or next week is quite unpredictable However, many stock price predictions are published every day by banks, financial institutions and independent analysts. We do not recommend to follow these stock price predictions without a critical thinking from your side, as their accuracy is usually low. For the last month we found 11 price targets for TMO stock:| Date | Analyst / Broker | Action | Previous target | Current target | Diff |
| 2019-7-25 | Needham & Company LLC | Raises Target | $315.00 | $321.00 | 1.9% |
| 2019-7-16 | Needham & Company LLC | Downgrades | n/a | $315.00 | - |
| 2019-5-23 | UBS Group | Raises Target | n/a | $320.00 | - |
| 2019-4-16 | Bank of America | Reiterates | $285.00 | $300.00 | 5.3% |
| 2019-3-26 | Robert W. Baird | Raises Target | $270.00 | $288.00 | 6.7% |
| 2019-3-26 | BTIG Research | Raises Target | n/a | $310.00 | - |
| 2019-3-25 | UBS Group | Raises Target | n/a | $305.00 | - |
| 2019-3-22 | Deutsche Bank | Raises Target | $275.00 | $300.00 | 9.1% |
| 2019-3-18 | Barclays | Raises Target | $295.00 | $300.00 | 1.7% |
| 2019-1-31 | BTIG Research | Raises Target | n/a | $290.00 | - |
| 2019-1-3 | Barclays | Raises Target | $275.00 | $280.00 | 1.8% |
| (in average) | $285.80 | $302.60 | 6.0% |
Financials and fundamental analysis
Earnings date and Earnings per Share
After publishing its last earnings report on April, Thermo Fisher Scientific . Unfortunately, reported EPS is not yet available in our database.| Quarter | Reporting date | Estimated EPS | Actual EPS | Surprise |
|---|---|---|---|---|
| 2017-Q2 | - | n/a | 1.63 | n/a |
| 2017-Q3 | 2017-10-25 | 2.25 | 2.31 | 2.7% |
| 2017-Q4 | 2018-01-31 | 2.66 | 2.79 | 4.9% |
| 2018-Q1 | 2018-04-25 | 2.42 | 2.5 | 3.3% |
| 2018-Q2 | 2018-07-25 | 2.63 | 2.75 | 4.6% |
| 2018-Q3 | 2018-10-24 | 2.55 | 2.62 | 2.7% |
| 2018-Q4 | 2019-01-30 | 3.19 | 3.25 | 1.9% |
| 2019-Q1 | 2019-04-23 | 2.74 | n/a | n/a |
| 2019-Q2 | - | n/a | n/a | n/a |
| 2019-Q3 | - | n/a | n/a | n/a |
Annual financial results
Compared to 2017, last anual revenues report draw an exceptional gain of 16.45% to $24,358.00 million USD. Nevertheless, its income margin (compared to revenues) grew to 12.06%, that is $2,938.00 million. To have an up to date picture of the financial situation of Thermo Fisher Scientific, we have calculated the trailing twelve month (TTM) sales and income figures. TTM values are the sum of the last 4 quarters and aproximate to an annual fiscal report ending in 2019-Q1 that can be compared to 2018 fiscal year results. Annual Thermo Fisher Scientific TTM sales up to March 2019 were $24,630.00 and income was $3,174.00 M USD. When comparing this TTM figures with the last reported annuality, we can esteem Thermo Fisher Scientific business evolution since December 2018: Annual turnover up to March, compared to lastest yearly report, gained a slightly good 1.12%. Regarding profit margin, Thermo Fisher Scientific stayed constant 0.82% to 12.06%| Year | Sales | YoY | Income/(margin) | YoY |
|---|---|---|---|---|
| 2013 | $13,090 M | - | $1,280 M9.8% | - |
| 2014 | $16,890 M | 29.03% | $1,894 M11.2% | 48.00% |
| 2015 | $16,965 M | 0.45% | $1,975 M11.6% | 4.28% |
| 2016 | $18,274 M | 7.71% | $2,022 M11.1% | 2.35% |
| 2017 | $20,918 M | 14.47% | $2,225 M10.6% | 10.05% |
| 2018 | $24,358 M | 16.45% | $2,938 M12.1% | 32.04% |
| TTM | $24,630 M | 1.12% | $3,174 M12.9% | 8.03% |
Quarterly financial results
Thermo Fisher Scientific reported $6,125.00 million in revenues for 2019-Q1, a -5.87% decline compared to previous quarter. Reported quarter income marked $815.00 million with a profit margin of 13.31%. Profit margin stayed constant a -0.49% compared to previous quarter when profit margin was 13.80%. When comparing revenues to same quarter last year, Thermo Fisher Scientific sales marked a good increase and appreciated a 4.65%.| Quarter | Sales1 | QoQ2 | Income1/(margin) | QoQ2 |
|---|---|---|---|---|
| 2017-Q2 | $4,990 M | - | $612 M12.3% | - |
| 2017-Q3 | $5,120 M | 2.61% | $534 M10.4% | -12.79% |
| 2017-Q4 | $6,047 M | 18.11% | $528 M8.7% | -1.11% |
| 2018-Q1 | $5,853 M | -3.21% | $579 M9.9% | 9.66% |
| 2018-Q2 | $6,078 M | 3.84% | $752 M12.4% | 29.88% |
| 2018-Q3 | $5,920 M | -2.60% | $709 M12.0% | -5.72% |
| 2018-Q4 | $6,507 M | 9.92% | $898 M13.8% | 26.66% |
| 2019-Q1 | $6,125 M | -5.87% | $815 M13.3% | -9.24% |
Thermo Fisher Scientific ownership
When you are planning to buy a stock, it's always worth to check its ownership structure.Management staff in all public traded companies that hold equity is required to report every transaction to the SEC. For Thermo Fisher Scientific, 0.19% of all outstanding shares are owned by its staff.
Bearish positions for TMO stock account 0.00%, no big difference from last month.
For a better understanding, the next table shows ownership data compared to other related stocks:
| TMO | A | BAX | BDX | BIO | |
|---|---|---|---|---|---|
| Market cap | $112.7 B | $23.1 B | $44.9 B | $69.8 B | $8.5 B |
| Total shares | 400.5 M | 309.5 M | 510.6 M | 270.0 M | 24.7 M |
| Float shares | 399.4 M | 308.5 M | 509.6 M | 269.1 M | 21.3 M |
| - Institutional holdings (%) | 90.7% | 88.2% | 88.2% | 87.5% | 78.0% |
| - Insider holdings (%) | 0.2% | 0.4% | 0.1% | 0.3% | 14.6% |
| Shares in short selling | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
TMO summary
| Friday, October 18th, 2019 | |
|---|---|
| Open | $281.05 |
| Close | $281.42 |
| Day range | $280.39 - $283.94 |
| Previous close | $281.59 |
| Session gain | -0.06% |
| Average true range | $7.26 |
| 50d mov avg | $283.92 |
| 100d mov avg | $285.20 |
| 200d mov avg | $271.64 |
| Daily pattern | lb01a |
| Weekly pattern | lb11a |
Thermo Fisher Scientific performance
To better understand Thermo Fisher Scientific performance you must compare its gains with other related stocks in same sector or industry. In the following table, we compare Thermo Fisher Scientific performance to Agilent Technologies, Baxter International, Becton, Dickinson and, Bio-Rad Laboratories, Danaher, Harvard Bioscience, Intuitive Surgical, PerkinElmer, Teleflex and Waters:| Stock | 3m | 6m | 12m |
|---|---|---|---|
| TMOThermo Fisher Sci... | -2.84% | 8.47% | 24.23% |
| AAgilent Technolog... | 8.78% | -1.67% | 16.70% |
| BAXBaxter Internatio... | 6.15% | 19.02% | 28.04% |
| BDXBecton, Dickinson... | 3.40% | 14.18% | 9.98% |
| BIOBio-Rad Laborator... | 8.91% | 16.71% | 22.18% |
| DHRDanaher | -2.43% | 9.12% | 38.20% |
| HBIOHarvard Bioscienc... | 46.15% | -30.66% | -33.57% |
| ISRGIntuitive Surgica... | 7.08% | 7.23% | 12.29% |
| PKIPerkinElmer | -11.36% | -11.60% | -3.27% |
| TFXTeleflex | -1.92% | 18.75% | 35.51% |
| WATWaters | 0.95% | -9.95% | 16.36% |
Thermo Fisher Scientific competitors
One check before trading any stock is to review a list of its competitors, in this case for Thermo Fisher Scientific. We chose 10 companies as Thermo Fisher Scientific competitors as they are in the same industry or have similar market objectives.- Agilent Technologies (A)
- Baxter International (BAX)
- Becton, Dickinson and (BDX)
- Bio-Rad Laboratories (BIO)
- Danaher (DHR)
- Harvard Bioscience (HBIO)
- Intuitive Surgical (ISRG)
- PerkinElmer (PKI)
- Teleflex (TFX)
- Waters (WAT)
Latest TMO stock news
- InvestorPlace3 Big Stock Charts for Friday: Thermo Fisher Scientific, Intuit and Intercontinental ExchangeJune 22, 2018